Harvard Bioscience (HBIO) Revenue (2010 - 2026)
Harvard Bioscience (HBIO) revenue from Jun 30, 2010 to Mar 31, 2026. The TTM Harvard Bioscience (HBIO) revenue is $86M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Revenue
Quarterly Revenue
Harvard Bioscience (HBIO) Revenue CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | -6.41% |
| 3 Years TTM | -9.27% |
| 5 Years TTM | -4.08% |
| 10 Years TTM | -2.47% |
| All Time TTM | +0.46% |
Annual Revenue change of Harvard Bioscience (HBIO)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $21M | -76.01% |
| 2025 | $87M | -8.06% |
| 2024 | $94M | -16.13% |
| 2023 | $112M | -0.96% |
| 2022 | $113M | -4.68% |
| 2021 | $119M | +16.45% |
| 2020 | $102M | +229.67% |
| 2019 | $31M | -74.36% |
| 2018 | $121M | +56.01% |
| 2017 | $77M | -25.94% |
| 2016 | $105M | -3.81% |
| 2015 | $109M | N/A |
| 2014 | $109M | +3.32% |
| 2013 | $105M | -5.40% |
| 2012 | $111M | +2.12% |
| 2011 | $109M | +0.63% |
| 2010 | $108M | +26.13% |
| 2009 | $86M | N/A |
Comparison Harvard Bioscience (HBIO) five years revenue CAGR with competitors
Harvard Bioscience (HBIO) five years revenue CAGR is -4.08%.